Seeking Alpha

AbbVie (ABBV) closed at $35.12 yesterday after opening at $34.40 following its spin-off from...

AbbVie (ABBV) closed at $35.12 yesterday after opening at $34.40 following its spin-off from Abbott Labs (ABT), giving it a market cap of $55.8B vs Abbott's $50.7B. AbbVie faces plenty of challenges, not least reducing its dependence on its $9B-per-year arthritis treatment Humira, which accounts for at least 70% of the company's profit but which will lose its patent protection in 2017.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector